US 10786512
DNA-PK inhibitors
granted A61KA61K31/506A61K31/5377
Quick answer
US patent 10786512 (DNA-PK inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/506, A61K31/5377, A61K31/5386, A61P